ĐÁNH GIÁ HIỆU QUẢ KỸ THUẬT CỦA ĐƯỜNG VÀO ĐỘNG MẠCH QUAY VÀ ĐỘNG MẠCH ĐÙI TRONG NÚT MẠCH ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN

Abstract

Background: In recent years, transradial access (TRA) has emerged as a new approach for transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). Objectives: To determine procedure’s success rate and to compare the benefits and complications between transradial and transfemoral artery embolization for Hepatocellular Carcinoma. Methods: Cross-sectional study with a retrospective analysis. From January 2019 to August 2021, 197 transarterial embolization procedures were performed on 132 patients in Gia Dinh People’s Hospital. 96 of which were transfemoral and the other 97 other cases were transradial. Results: Sucess rate of transradial chemoembolization in HCC was similar to a transfemoral procedure, differences were not statistically significant (100% and 99%; p=0.497). Local vascular complication rate of radial access was lower than that of femoral access but was also statistically unsignificant (1% and 3.1%; p=0.368). Total procedure timing, irradiation time and radiation dose of a radial access were lower than that of a femoral access. But again, differences were not statistically significant. Conclusions: Transradial chemoembolization in HCC treatment has the same success rate, complication rate as well as technical characteristics as a transfemoral access procedure. With proven benefits and patient’s comfort, transradial access is feasible and can be applied in clinical practice of HCC chemoembolization.